Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

miR-497 suppresses cycle progression through an axis involving CDK6 in ALK-positive cells.

Hoareau-Aveilla C, Quelen C, Congras A, Caillet N, Labourdette D, Dozier C, Brousset P, Lamant L, Meggetto F.

Haematologica. 2019 Feb;104(2):347-359. doi: 10.3324/haematol.2018.195131. Epub 2018 Sep 27.

2.

Doxorubicin-induced loss of DNA topoisomerase II and DNMT1- dependent suppression of MiR-125b induces chemoresistance in ALK-positive cells.

Congras A, Caillet N, Torossian N, Quelen C, Daugrois C, Brousset P, Lamant L, Meggetto F, Hoareau-Aveilla C.

Oncotarget. 2018 Feb 8;9(18):14539-14551. doi: 10.18632/oncotarget.24465. eCollection 2018 Mar 6.

3.

Crosstalk between microRNA and DNA Methylation Offers Potential Biomarkers and Targeted Therapies in ALK-Positive Lymphomas.

Hoareau-Aveilla C, Meggetto F.

Cancers (Basel). 2017 Aug 3;9(8). pii: E100. doi: 10.3390/cancers9080100. Review.

4.

Reversal of microRNA-150 silencing disadvantages crizotinib-resistant NPM-ALK(+) cell growth.

Hoareau-Aveilla C, Valentin T, Daugrois C, Quelen C, Mitou G, Quentin S, Jia J, Spicuglia S, Ferrier P, Ceccon M, Giuriato S, Gambacorti-Passerini C, Brousset P, Lamant L, Meggetto F.

J Clin Invest. 2015 Sep;125(9):3505-18. doi: 10.1172/JCI78488. Epub 2015 Aug 10.

5.

MicroRNA and ALK-positive anaplastic large cell lymphoma.

Hoareau-Aveilla C, Merkel O, Meggetto F.

Front Biosci (Schol Ed). 2015 Jun 1;7:217-25. Review.

PMID:
25961697
6.

Alternative splicing of TIA-1 in human colon cancer regulates VEGF isoform expression, angiogenesis, tumour growth and bevacizumab resistance.

Hamdollah Zadeh MA, Amin EM, Hoareau-Aveilla C, Domingo E, Symonds KE, Ye X, Heesom KJ, Salmon A, D'Silva O, Betteridge KB, Williams AC, Kerr DJ, Salmon AH, Oltean S, Midgley RS, Ladomery MR, Harper SJ, Varey AH, Bates DO.

Mol Oncol. 2015 Jan;9(1):167-78. doi: 10.1016/j.molonc.2014.07.017. Epub 2014 Aug 20.

7.

Ribosomal protein S6 kinase activity controls the ribosome biogenesis transcriptional program.

Chauvin C, Koka V, Nouschi A, Mieulet V, Hoareau-Aveilla C, Dreazen A, Cagnard N, Carpentier W, Kiss T, Meyuhas O, Pende M.

Oncogene. 2014 Jan 23;33(4):474-83. doi: 10.1038/onc.2012.606. Epub 2013 Jan 14.

PMID:
23318442
8.

10th Francophone Yeast Meeting 'Levures, Modèles & Outils'.

Martin-Yken H, Ribaud V, Poli J, Hoareau-Aveilla C, Spichal M, Beaufort S, Tilloy V, Delerue T, Capp JP, Parrou JL.

Res Microbiol. 2012 Jun;163(5):309-15. doi: 10.1016/j.resmic.2012.05.007. Epub 2012 May 31. No abstract available.

PMID:
22705268
9.

Mammalian HCA66 protein is required for both ribosome synthesis and centriole duplication.

Bonnart C, Gérus M, Hoareau-Aveilla C, Kiss T, Caizergues-Ferrer M, Henry Y, Henras AK.

Nucleic Acids Res. 2012 Jul;40(13):6270-89. doi: 10.1093/nar/gks234. Epub 2012 Mar 20.

10.

Utp23p is required for dissociation of snR30 small nucleolar RNP from preribosomal particles.

Hoareau-Aveilla C, Fayet-Lebaron E, Jády BE, Henras AK, Kiss T.

Nucleic Acids Res. 2012 Apr;40(8):3641-52. doi: 10.1093/nar/gkr1213. Epub 2011 Dec 17.

11.

The anti-angiogenic isoforms of VEGF in health and disease.

Qiu Y, Hoareau-Aveilla C, Oltean S, Harper SJ, Bates DO.

Biochem Soc Trans. 2009 Dec;37(Pt 6):1207-13. doi: 10.1042/BST0371207.

12.

Regulation of vascular endothelial growth factor (VEGF) splicing from pro-angiogenic to anti-angiogenic isoforms: a novel therapeutic strategy for angiogenesis.

Nowak DG, Amin EM, Rennel ES, Hoareau-Aveilla C, Gammons M, Damodoran G, Hagiwara M, Harper SJ, Woolard J, Ladomery MR, Bates DO.

J Biol Chem. 2010 Feb 19;285(8):5532-40. doi: 10.1074/jbc.M109.074930. Epub 2009 Nov 11.

13.

[Dyskeratosis congenita, a disease caused by defective telomere maintenance].

Hoareau-Aveilla C, Henry Y, Leblanc T.

Med Sci (Paris). 2008 Apr;24(4):390-8. doi: 10.1051/medsci/2008244390. Review. French.

14.

The box H/ACA RNP assembly factor Naf1p contains a domain homologous to Gar1p mediating its interaction with Cbf5p.

Leulliot N, Godin KS, Hoareau-Aveilla C, Quevillon-Cheruel S, Varani G, Henry Y, Van Tilbeurgh H.

J Mol Biol. 2007 Aug 31;371(5):1338-53. Epub 2007 Jun 16.

PMID:
17612558
15.

hNaf1 is required for accumulation of human box H/ACA snoRNPs, scaRNPs, and telomerase.

Hoareau-Aveilla C, Bonoli M, Caizergues-Ferrer M, Henry Y.

RNA. 2006 May;12(5):832-40. Epub 2006 Apr 6.

Supplemental Content

Loading ...
Support Center